|
|
|
Insider
Information: |
Nashat Amir |
Relationship: |
Director, 10% Owner |
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
8 |
|
Direct
Shares |
51,211 |
|
Indirect Shares
|
2,932,442 |
|
|
Direct
Value |
$338,447 |
|
|
Indirect Value
|
$43,278,680 |
|
|
Total
Shares |
2,983,653 |
|
|
Total
Value |
$43,617,127 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Receptos, Inc. |
RCPT |
Director |
2013-05-14 |
0 |
2014-05-27 |
274 |
Premium* |
|
Fate Therapeutics Inc |
FATE |
Director |
2013-10-04 |
0 |
2019-08-01 |
11,034 |
Premium* |
|
aTyr Pharma Inc |
LIFE |
Former 10% Owner, Dire... |
2015-05-12 |
12,572 |
2015-05-12 |
17,638 |
Premium* |
|
Cartesian Therapeutics, Inc |
RNAC |
Director |
|
0 |
2019-01-25 |
2,676,234 |
Premium* |
|
Syros Pharmaceuticals, Inc. |
SYRS |
Director, 10% Owner |
2016-07-06 |
0 |
2016-07-06 |
48,320 |
Premium* |
|
Scholar Rock Holding Corp |
SRRK |
|
2024-05-09 |
38,639 |
2024-05-09 |
0 |
Premium* |
|
Morphic Holding, Inc. |
MORF |
|
2024-08-16 |
0 |
2024-08-16 |
0 |
Premium* |
|
Metacrine, Inc. |
MTCR |
Director, 10% Owner |
2020-09-18 |
0 |
2020-09-18 |
178,942 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
76 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
FATE |
Fate Therapeutics Inc |
Director |
|
2013-10-04 |
4 |
A |
$6.00 |
$770,676 |
I/I |
128,446 |
1,639,853 |
0 |
- |
|
FATE |
Fate Therapeutics Inc |
Director |
|
2013-10-04 |
4 |
A |
$0.00 |
$0 |
I/I |
1,511,407 |
1,511,407 |
0 |
- |
|
FATE |
Fate Therapeutics Inc |
Director |
|
2013-10-04 |
4 |
B |
$6.00 |
$4,999,998 |
I/I |
833,333 |
2,473,186 |
2.25 |
- |
|
FATE |
Fate Therapeutics Inc |
Director |
|
2018-12-11 |
4 |
S |
$16.71 |
$1,379,183 |
I/I |
(82,528) |
2,390,658 |
0 |
- |
|
FATE |
Fate Therapeutics Inc |
Director |
|
2018-12-12 |
4 |
S |
$16.78 |
$7,132,690 |
I/I |
(425,000) |
1,965,658 |
0 |
- |
|
FATE |
Fate Therapeutics Inc |
Director |
|
2018-12-13 |
4 |
S |
$16.67 |
$296,563 |
I/I |
(17,788) |
1,947,870 |
0 |
- |
|
FATE |
Fate Therapeutics Inc |
Director |
|
2018-12-19 |
4 |
S |
$13.17 |
$1,222,592 |
I/I |
(91,210) |
1,856,660 |
0 |
- |
|
FATE |
Fate Therapeutics Inc |
Director |
|
2018-12-20 |
4 |
S |
$12.25 |
$410,160 |
I/I |
(33,474) |
1,823,186 |
0 |
- |
|
FATE |
Fate Therapeutics Inc |
Director |
|
2019-01-18 |
4 |
S |
$16.28 |
$642,834 |
I/I |
(39,483) |
1,783,703 |
0 |
- |
|
FATE |
Fate Therapeutics Inc |
Director |
|
2019-01-25 |
4 |
S |
$14.14 |
$1,272,753 |
I/I |
(90,000) |
1,693,703 |
0 |
- |
|
FATE |
Fate Therapeutics Inc |
Director |
|
2019-01-28 |
4 |
S |
$13.78 |
$964,768 |
I/I |
(70,000) |
1,623,703 |
0 |
- |
|
FATE |
Fate Therapeutics Inc |
Director |
|
2019-01-29 |
4 |
S |
$14.16 |
$1,380,795 |
I/I |
(97,500) |
1,526,203 |
0 |
- |
|
FATE |
Fate Therapeutics Inc |
Director |
|
2019-01-30 |
4 |
S |
$14.16 |
$750,959 |
I/I |
(53,017) |
1,473,186 |
0 |
- |
|
FATE |
Fate Therapeutics Inc |
Director |
|
2019-07-18 |
4 |
AS |
$22.50 |
$481,795 |
I/I |
(21,409) |
14,056 |
0 |
- |
|
FATE |
Fate Therapeutics Inc |
Director |
|
2019-07-19 |
4 |
AS |
$22.50 |
$23,693 |
I/I |
(1,053) |
14,046 |
0 |
- |
|
FATE |
Fate Therapeutics Inc |
Director |
|
2019-07-22 |
4 |
AS |
$22.52 |
$1,097,019 |
I/I |
(48,704) |
13,574 |
0 |
- |
|
FATE |
Fate Therapeutics Inc |
Director |
|
2019-07-23 |
4 |
AS |
$22.51 |
$1,396,053 |
I/I |
(62,033) |
12,973 |
0 |
- |
|
FATE |
Fate Therapeutics Inc |
Director |
|
2019-07-24 |
4 |
AS |
$22.51 |
$447,098 |
I/I |
(19,866) |
12,781 |
0 |
- |
|
FATE |
Fate Therapeutics Inc |
Director |
|
2019-07-26 |
4 |
AS |
$22.50 |
$626,153 |
I/I |
(27,829) |
12,511 |
0 |
- |
|
FATE |
Fate Therapeutics Inc |
Director |
|
2019-07-29 |
4 |
AS |
$22.50 |
$7,403 |
I/I |
(329) |
12,508 |
0 |
- |
|
FATE |
Fate Therapeutics Inc |
Director |
|
2019-07-30 |
4 |
AS |
$22.51 |
$2,029,560 |
I/I |
(90,175) |
11,635 |
0 |
- |
|
FATE |
Fate Therapeutics Inc |
Director |
|
2019-07-31 |
4 |
AS |
$22.53 |
$701,674 |
I/I |
(31,139) |
11,333 |
0 |
- |
|
FATE |
Fate Therapeutics Inc |
Director |
|
2019-08-01 |
4 |
AS |
$22.53 |
$695,392 |
I/I |
(30,866) |
11,034 |
0 |
- |
|
LIFE |
aTyr Pharma Inc |
Director |
|
2015-05-06 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
12,572 |
|
- |
|
LIFE |
aTyr Pharma Inc |
Former 10% Owner |
|
2015-05-12 |
4 |
A |
$0.00 |
$0 |
I/I |
1,827,992 |
17,638 |
0 |
- |
|
76 Records found
|
|
Page 1 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|